▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4148 by analyst upside · 2026-09-29
INSP
Inspire Medical Systems, Inc.
Healthcare · Market Cap $2B · P/E 15.6x
ANALYST PRICE TARGET
-10.3%
implied upside to consensus target
Current Price $70.0
Consensus Target $62.8
Bull Target $97.0
Bear Target $40.0
Analysts Covering 15
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
4
Hold
10
Sell
1
52-Week Low $38.91
52-Week High $147.03
YTD Return -24.1%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) 15.6x
Forward P/E 45.5x
EPS (TTM) $4.50
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $899M
Profit Margin 15.0%
52-WEEK RANGE
52-Week Low $38.91
52-Week High $147.03
Current Price $70.0
Bear Target $40.0
Bull Target $97.0
● Now $70.0 ● Target $62.8
TRADING DATA
Avg Volume 797K
YTD Return -24.1%
Analyst Count 15
Consensus Hold
Upside to Target -10.3%
Last Updated 2026-09-29

ANALYST SUMMARY

Inspire Medical Systems, Inc. (INSP) is currently trading at $70.0 with a Wall Street consensus price target of $62.8, which is 10.3% below the current price over the next 12 months. 15 analysts currently cover INSP, with a consensus rating of Hold - 27% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $97.0, while the most cautious has a target of $40.0.

INSP operates in the Healthcare sector with a market capitalisation of $2B. The stock is down 24.1% year-to-date and is currently trading near the lower end of its 52-week range of $38.91 – $147.03.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for INSP, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Freedom Capital Markets - Reiterated
Buy → Buy 2026-09-21 Building track record
Stifel - Reiterated
Buy → Buy 2026-09-11 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-08-04 43% win rate (7 calls)
Mizuho - Reiterated
Outperform → Outperform 2026-08-04 Building track record
Oppenheimer ↑ Upgrade
Perform → Outperform 2026-08-04 14% win rate (7 calls)
Truist Securities reit
Hold → Hold 2026-08-04 Building track record
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-08-04 Building track record
Piper Sandler - Reiterated
Neutral → Neutral 2026-08-04 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
37
out of 100
Coverage depth
21/30
Consensus clarity
14/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →